BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32329404)

  • 1. Pharmacy's Call for Authorities to Aggressively Enforce Laws Addressing Price Gouging.
    Mattingly TJ; Hogue MD
    J Manag Care Spec Pharm; 2020 Aug; 26(8):952-955. PubMed ID: 32329404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 and Drug Shortages: A Call to Action.
    Shuman AG; Fox ER; Unguru Y
    J Manag Care Spec Pharm; 2020 Aug; 26(8):945-947. PubMed ID: 32715960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic pharmacy leadership during the COVID-19 crisis: Optimizing patient care through formulary and drug shortage management.
    Pulk RA; Leber M; Tran L; Ammar M; Amin N; Miller L; Yazdi M
    Am J Health Syst Pharm; 2020 Oct; 77(22):1874-1884. PubMed ID: 32710774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The healthcare and pharmaceutical vulnerability emerging from the new Coronavirus outbreak.
    Leonardi Vinci D; Polidori C; Polidori P
    Eur J Hosp Pharm; 2020 May; 27(3):129-130. PubMed ID: 32419930
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacy preparedness and response for the prevention and control of coronavirus disease (COVID-19) in Aksum, Ethiopia; a qualitative exploration.
    Kasahun GG; Kahsay GM; Asayehegn AT; Demoz GT; Desta DM; Gebretekle GB
    BMC Health Serv Res; 2020 Oct; 20(1):913. PubMed ID: 33008384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Specialty Drug Price Trends Using Data from Retrospective Pharmacy Sales Transactions.
    Penington R; Stubbings JA
    J Manag Care Spec Pharm; 2016 Sep; 22(9):1010-7. PubMed ID: 27574742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National trends in prescription drug expenditures and projections for 2021.
    Tichy EM; Hoffman JM; Suda KJ; Rim MH; Tadrous M; Cuellar S; Clark JS; Wiest MD; Matusiak LM; Schumock GT
    Am J Health Syst Pharm; 2021 Jul; 78(14):1294-1308. PubMed ID: 33880494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies.
    Badreldin HA; Atallah B
    Res Social Adm Pharm; 2021 Jan; 17(1):1946-1949. PubMed ID: 32446652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication Shortages During the COVID-19 Crisis: What We Must Do.
    Choo EK; Rajkumar SV
    Mayo Clin Proc; 2020 Jun; 95(6):1112-1115. PubMed ID: 32312491
    [No Abstract]   [Full Text] [Related]  

  • 12. Hospital Pharmacy Service: Facing the logistics of medicines procurement.
    Palomar-Fernández C; Álvarez-Díaz A
    Farm Hosp; 2020 Jun; 44(7):17-20. PubMed ID: 32533663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State prescription drug price Web sites: how useful to consumers?
    Tu HT; Corey CG
    Res Brief; 2008 Feb; (1):1-16. PubMed ID: 18494180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information.
    Hoti K; Jakupi A; Hetemi D; Raka D; Hughes J; Desselle S
    Int J Clin Pharm; 2020 Aug; 42(4):1197-1206. PubMed ID: 32524513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of COVID-19 on the global supply chain of antiretroviral drugs: a rapid survey of Indian manufacturers.
    Rewari BB; Mangadan-Konath N; Sharma M
    WHO South East Asia J Public Health; 2020 Sep; 9(2):126-133. PubMed ID: 32978345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: Data from community pharmacies.
    Romano S; Galante H; Figueira D; Mendes Z; Rodrigues AT
    Res Social Adm Pharm; 2021 Jan; 17(1):1876-1881. PubMed ID: 32482587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Learning to Hoard: The Effects of Preexisting and Surprise Price-Gouging Regulation During the COVID-19 Pandemic.
    Chakraborti R; Roberts G
    J Consum Policy (Dordr); 2021; 44(4):507-529. PubMed ID: 34366523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abandoning List Prices In Medicaid Drug Reimbursement Did Not Affect Spending.
    Ippolito B; Levy JF; Anderson GF
    Health Aff (Millwood); 2020 Jul; 39(7):1202-1209. PubMed ID: 32634350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Providing pharmacy services during the coronavirus pandemic.
    Liu S; Luo P; Tang M; Hu Q; Polidoro JP; Sun S; Gong Z
    Int J Clin Pharm; 2020 Apr; 42(2):299-304. PubMed ID: 32222911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.